Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new pulmicort clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on pulmicort
- Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma
Status: Recruiting, Condition Summary: Asthma - Phase4/Symbicort Versus Pulmicort Flexhaler in African Americans
Status: Recruiting, Condition Summary: Asthma - A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880)
Status: Recruiting, Condition Summary: Asthma - Childhood Asthma Research and Education (CARE) Network Trial - Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (The MIST Study)
Status: Not yet recruiting, Condition Summary: Asthma - Effects of Budesonide & Budesonide/Formoterol on Smoking Asthmatic Subjects
Status: Completed, Condition Summary: Asthma - Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children
Status: Recruiting, Condition Summary: Asthma - Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia
Status: Completed, Condition Summary: Lung Cancer - Randomized Placebo Controlled Trial of Budesonide-MMX™ 6 mg and 9 mg in Patients With Ulcerative Colitis
Status: Not yet recruiting, Condition Summary: Ulcerative Colitis - Randomized Placebo Controlled Trial of Budesonide-MMX™ (CB-01-02) 6 mg and 9 mg in Patients With Ulcerative Colitis
Status: Not yet recruiting, Condition Summary: Ulcerative Colitis - Budesonide Inhalation Suspension for Acute Asthma in Children
Status: Completed, Condition Summary: Asthma; Acute Asthma; Reactive Airway Exacerbation - Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
Status: Completed, Condition Summary: Bronchial Asthma - Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients
Status: Recruiting, Condition Summary: Cough Variant Asthma - Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5
Status: Completed, Condition Summary: Asthma - Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5
Status: Completed, Condition Summary: Asthma - Titratable Dosing in Moderate to Severe Asthmatics
Status: Completed, Condition Summary: Asthma - Symbicort in Asthmatic Children - SEEDLING
Status: Completed, Condition Summary: Asthma - Long-Term Safety of Symbicort in Asthmatic Children - SAPLING
Status: Completed, Condition Summary: Asthma - Children, Perennial Allergic Rhinitis (PAR), l-t Growth
Status: Completed, Condition Summary: Perennial Allergic Rhinitis - New Nasal Applicator / New Formulation - User Study
Status: Completed, Condition Summary: Seasonal Allergic Rhinitis - Rhinocort Aqua Versus Placebo and Fluticasone Propionate
Status: Completed, Condition Summary: Seasonal Allergic Rhinitis - Inhaled Steroid Treatment as Regular Therapy in Early Asthma
Status: Completed, Condition Summary: Asthma - Varicella Vaccination With Pulmicort
Status: Completed, Condition Summary: Asthma - Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children
Status: Completed, Condition Summary: Asthma - An Efficacy Study Comparing SYMBICORT® pMDI With Budesonide HFA pMDI, in Hispanic Subjects With ICS Dependent Asthma
Status: Active, not recruiting, Condition Summary: Asthma - Adults With Moderate to Severe Asthma
Status: Completed, Condition Summary: Asthma - New Version Pulmicort Turbuhaler USA Adults
Status: Completed, Condition Summary: Asthma - Assess the Efficacy and Safety of Rhinocort Aqua
Status: Completed, Condition Summary: Allergic Rhinitis - New Version Pulmicort Turbuhaler USA Children
Status: Completed, Condition Summary: Asthma - Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations
Status: Completed, Condition Summary: Asthma - Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD
Status: Recruiting, Condition Summary: Chronic Obstructive Pulmonary Disease